• Organization of two symposiums on October 13 and 14
• Presentation of Vectorio®, an innovative medical device, at the "Interventional Radiology Village"
Villepinte (France), October 9, 2017 (8:30 CEST) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, today announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will be held in Paris from October 13 to 16, 2017[1].
The JFR, a major international gathering for medical imaging players, annually brings together more than 17,000 diagnostic and interventional radiology experts from France and abroad. This year, the JFR, a place for discussion and debate focusing on innovation, research and development, will place emphasis on the theme "Patients and their Radiologists".
Guerbet will present its integrated MRI and scanner offers as well as its digital solutions. For the 6th consecutive year, Guerbet will also be an exhibitor and partner of the "Interventional Radiology Village" where, for the first time, it will present Vectorio®, its innovative medical device that obtained the CE mark in September 2017[2].
Designed in collaboration with interventional radiologists worldwide, Vectorio® is a unique set of medical devices that are resistant to Lipiodol® Ultra Fluide, used for conventional Trans-Arterial Chemo-Embolization (cTACE) Guerbet will also organize two symposiums during the JFR:
- "Gadolinium deposits in the brain: what is the current situation?", on Friday, October 13 from 12h30 to 13h30 - Prof. Fabrice BONNEVILLE (Toulouse University Hospital) will be the moderator and findings will be presented by Prof. Douraied Ben Salem (Brest University Hospital), Dr Nicolas Menjot De Champfleur (Montpellier University Hospital), Prof. François Cotton (Lyon Public Hospital) and Prof. Isabelle Thomassin (Tenon Public Hospital, Paris).
- "Guerbet, the present and future in interventional radiology", on Saturday, October 14 from 12h30 to 13h30 - Prof. Afshin Gangi (Strasbourg University Hospital) will be the moderator and Prof. Jean-Pierre Pelage (Caen University Hospital), Prof. Patrick Chevallier (Nice University Hospital) and Prof. Romaric Loffroy (Dijon University hospital) will all present their work.
The Guerbet team will be present at stand No. 101 in the Passy Hall and at stand J in the Interventional Radiology Village.
About Vectorio®
Vectorio® is a class Is (CE 0459) sterile medical device designed to be used by healthcare professionals only. It is a Lipiodol® Ultra Fluide-resistant mixing and injection system for Trans-Arterial Chemo-Embolization (cTACE) procedures. For more information, please refer to your country's local Package Information Leaflet and the Vectorio® Instructions For Use (IFU). Vectorio® is manufactured by Medex, a Guerbet Group subsidiary.
• Presentation of Vectorio®, an innovative medical device, at the "Interventional Radiology Village"
Villepinte (France), October 9, 2017 (8:30 CEST) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, today announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will be held in Paris from October 13 to 16, 2017[1].
The JFR, a major international gathering for medical imaging players, annually brings together more than 17,000 diagnostic and interventional radiology experts from France and abroad. This year, the JFR, a place for discussion and debate focusing on innovation, research and development, will place emphasis on the theme "Patients and their Radiologists".
Guerbet will present its integrated MRI and scanner offers as well as its digital solutions. For the 6th consecutive year, Guerbet will also be an exhibitor and partner of the "Interventional Radiology Village" where, for the first time, it will present Vectorio®, its innovative medical device that obtained the CE mark in September 2017[2].
Designed in collaboration with interventional radiologists worldwide, Vectorio® is a unique set of medical devices that are resistant to Lipiodol® Ultra Fluide, used for conventional Trans-Arterial Chemo-Embolization (cTACE) Guerbet will also organize two symposiums during the JFR:
- "Gadolinium deposits in the brain: what is the current situation?", on Friday, October 13 from 12h30 to 13h30 - Prof. Fabrice BONNEVILLE (Toulouse University Hospital) will be the moderator and findings will be presented by Prof. Douraied Ben Salem (Brest University Hospital), Dr Nicolas Menjot De Champfleur (Montpellier University Hospital), Prof. François Cotton (Lyon Public Hospital) and Prof. Isabelle Thomassin (Tenon Public Hospital, Paris).
- "Guerbet, the present and future in interventional radiology", on Saturday, October 14 from 12h30 to 13h30 - Prof. Afshin Gangi (Strasbourg University Hospital) will be the moderator and Prof. Jean-Pierre Pelage (Caen University Hospital), Prof. Patrick Chevallier (Nice University Hospital) and Prof. Romaric Loffroy (Dijon University hospital) will all present their work.
The Guerbet team will be present at stand No. 101 in the Passy Hall and at stand J in the Interventional Radiology Village.
About Vectorio®
Vectorio® is a class Is (CE 0459) sterile medical device designed to be used by healthcare professionals only. It is a Lipiodol® Ultra Fluide-resistant mixing and injection system for Trans-Arterial Chemo-Embolization (cTACE) procedures. For more information, please refer to your country's local Package Information Leaflet and the Vectorio® Instructions For Use (IFU). Vectorio® is manufactured by Medex, a Guerbet Group subsidiary.
